4P-Pharma est dans l’émission « Les Grands Paris de l’Entreprise »

4P-Pharma, a clinical-stage biotechnology company and the research center Institut de la Vision (Sorbonne Université, Inserm, CNRS) establish a partnership agreement for the development of 4P020, a promising therapeutic approach for dry age-related macular degeneration (dAMD) and Stargardt disease with the support of the SATT Lutech. This drug candidate, initially studied by Dr Valerie Fontaine at the Institut de la Vision, opens&hellip

4P-Pharma was featured in an article in Eco121, the North region economic magazine.  Lille and the North region , is a very dynamic area for biotech, and we are pleased to benefit from the collaboration of Lille Pasteur Institute and Eurasanté. Find the article written by O. Ducuing, here: http://www.eco121.fr/categorie/theme/entreprendre/